Rui Gou

850 total citations
28 papers, 547 citations indexed

About

Rui Gou is a scholar working on Molecular Biology, Cancer Research and Reproductive Medicine. According to data from OpenAlex, Rui Gou has authored 28 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 12 papers in Cancer Research and 8 papers in Reproductive Medicine. Recurrent topics in Rui Gou's work include Cancer-related molecular mechanisms research (9 papers), Ovarian cancer diagnosis and treatment (8 papers) and Ferroptosis and cancer prognosis (7 papers). Rui Gou is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), Ovarian cancer diagnosis and treatment (8 papers) and Ferroptosis and cancer prognosis (7 papers). Rui Gou collaborates with scholars based in China, Germany and United States. Rui Gou's co-authors include Bei Lin, Yuexin Hu, Mingjun Zheng, Xin Nie, Hui Dong, Juanjuan Liu, Ouxuan Liu, Lingling Gao, Xiao Li and Xiao Li and has published in prestigious journals such as The FASEB Journal, Life Sciences and Journal of Cellular Physiology.

In The Last Decade

Rui Gou

28 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rui Gou China	16	367	248	144	120	69	28	547
Yuexin Hu China	16	345 0.9×	247 1.0×	141 1.0×	115 1.0×	65 0.9×	36	527
Tianshui Sun China	9	456 1.2×	179 0.7×	85 0.6×	137 1.1×	54 0.8×	14	556
Sundersingh Shirley India	8	246 0.7×	115 0.5×	65 0.5×	116 1.0×	59 0.9×	14	430
Joema Felipe Lima United States	10	264 0.7×	214 0.9×	76 0.5×	242 2.0×	39 0.6×	15	535
Arpita Desai United States	10	229 0.6×	116 0.5×	185 1.3×	165 1.4×	31 0.4×	38	451
Mingzi Tan China	16	339 0.9×	176 0.7×	55 0.4×	125 1.0×	160 2.3×	28	615
Xiao Huo China	14	470 1.3×	348 1.4×	90 0.6×	73 0.6×	46 0.7×	30	626
Yuandong Liao China	11	337 0.9×	320 1.3×	67 0.5×	90 0.8×	46 0.7×	19	499
Catherine J. Kennedy Australia	13	234 0.6×	119 0.5×	176 1.2×	194 1.6×	26 0.4×	25	560
Michał Świerniak Poland	12	393 1.1×	315 1.3×	65 0.5×	69 0.6×	45 0.7×	19	627

Countries citing papers authored by Rui Gou

Since Specialization

Citations

This map shows the geographic impact of Rui Gou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Gou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Gou more than expected).

Fields of papers citing papers by Rui Gou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Gou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Gou. The network helps show where Rui Gou may publish in the future.

Co-authorship network of co-authors of Rui Gou

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Gou. A scholar is included among the top collaborators of Rui Gou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Gou. Rui Gou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Huan, Rui Gou, Wei Li, et al.. (2025). Targeting Delivery of Dexamethasone to Inflamed Joints by Albumin-Binding Peptide Modified Liposomes for Rheumatoid Arthritis Therapy. International Journal of Nanomedicine. Volume 20. 3789–3802. 2 indexed citations

Gou, Rui, et al.. (2025). Low level of lactate and trophoblast dysfunction mediated by SNAI1/PDK1 contributes to miscarriage. Placenta. 165. 33–41. 1 indexed citations

Nie, Xin, Lingling Gao, Mingjun Zheng, et al.. (2024). ST14 interacts with TMEFF1 and is a predictor of poor prognosis in ovarian cancer. BMC Cancer. 24(1). 330–330. 2 indexed citations

Gou, Rui, et al.. (2023). Glycolysis: A fork in the path of normal and pathological pregnancy. The FASEB Journal. 37(12). 21 indexed citations

Gou, Rui, Xiao Li, Hui Dong, et al.. (2022). RAD21 Confers Poor Prognosis and Affects Ovarian Cancer Sensitivity to Poly(ADP-Ribose)Polymerase Inhibitors Through DNA Damage Repair. Frontiers in Oncology. 12. 936550–936550. 9 indexed citations

Gao, Lingling, Xin Nie, Rui Gou, et al.. (2021). Exosomal ANXA2 derived from ovarian cancer cells regulates epithelial‐mesenchymal plasticity of human peritoneal mesothelial cells. Journal of Cellular and Molecular Medicine. 25(23). 10916–10929. 33 indexed citations

Hu, Yuexin, Mingjun Zheng, Shuang Wang, et al.. (2021). Identification of a five-gene signature of the RGS gene family with prognostic value in ovarian cancer. Genomics. 113(4). 2134–2144. 43 indexed citations

Gou, Rui, Yuexin Hu, Ouxuan Liu, et al.. (2021). PGK1 Is a Key Target for Anti-Glycolytic Therapy of Ovarian Cancer: Based on the Comprehensive Analysis of Glycolysis-Related Genes. Frontiers in Oncology. 11. 682461–682461. 24 indexed citations

Zheng, Mingjun, Yuexin Hu, Rui Gou, et al.. (2021). Development of a seven-gene tumor immune microenvironment prognostic signature for high-risk grade III endometrial cancer. Molecular Therapy — Oncolytics. 22. 294–306. 13 indexed citations

10.

Gao, Lingling, Xin Nie, Rui Gou, et al.. (2021). Interaction of CD147 and human epididymis protein 4 promotes invasion and metastasis of ovarian cancer. Journal of Cancer. 12(24). 7422–7435. 7 indexed citations

11.

Li, Xiao, Caixia Wang, Shuang Wang, et al.. (2021). YWHAE as an HE4 interacting protein can influence the malignant behaviour of ovarian cancer by regulating the PI3K/AKT and MAPK pathways. Cancer Cell International. 21(1). 15 indexed citations

12.

Zheng, Mingjun, Yuexin Hu, Rui Gou, et al.. (2020). Identification of immune‐enhanced molecular subtype associated with BRCA1 mutations, immune checkpoints and clinical outcome in ovarian carcinoma. Journal of Cellular and Molecular Medicine. 24(5). 2819–2831. 22 indexed citations

13.

Zheng, Mingjun, Yuexin Hu, Rui Gou, et al.. (2020). Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation. Biomedicine & Pharmacotherapy. 124. 109810–109810. 46 indexed citations

14.

Wang, Shuang, Caixia Wang, Xiao Li, et al.. (2020). Down-regulation of TRIB3 inhibits the progression of ovarian cancer via MEK/ERK signaling pathway. Cancer Cell International. 20(1). 418–418. 21 indexed citations

15.

Wang, Shuang, Caixia Wang, Yuexin Hu, et al.. (2020). ZNF703 promotes tumor progression in ovarian cancer by interacting with HE4 and epigenetically regulating PEA15. Journal of Experimental & Clinical Cancer Research. 39(1). 264–264. 19 indexed citations

16.

Hu, Yuexin, Mingjun Zheng, Caixia Wang, et al.. (2020). Identification of KIF23 as a prognostic signature for ovarian cancer based on large-scale sampling and clinical validation.. PubMed. 12(9). 4955–4976. 15 indexed citations

17.

Gou, Rui, Hui Dong, & Bei Lin. (2020). Application and reflection of genomic scar assays in evaluating the efficacy of platinum salts and PARP inhibitors in cancer therapy. Life Sciences. 261. 118434–118434. 24 indexed citations

18.

Hu, Yuexin, Mingjun Zheng, Wenchao Zhang, et al.. (2019). Systematic profiling of alternative splicing signature reveals prognostic predictor for cervical cancer. Journal of Translational Medicine. 17(1). 379–379. 26 indexed citations

19.

Zheng, Mingjun, Rui Gou, Wenchao Zhang, et al.. (2018). Screening of prognostic biomarkers for endometrial carcinoma based on a ceRNA network. PeerJ. 6. e6091–e6091. 10 indexed citations

20.

Zheng, Mingjun, Jing Wang, Huimin Wang, et al.. (2018). Decreased expression of peroxiredoxin1 inhibits proliferation, invasion, and metastasis of ovarian cancer cell. OncoTargets and Therapy. Volume 11. 7745–7761. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact